Chromosomal translocations with breakpoints in T-cell receptor (TCR) genes are recurrent in T-cell malignancies. These translocations involve the TCRad gene (14q11), the TCRb gene (7q34) and to a lesser extent the TCRc gene at chromosomal band 7p14 and juxtapose T-cell oncogenes next to TCR regulatory sequences leading to deregulated expression of those oncogenes. Here, we describe a new recurrent chromosomal inversion of chromosome 7, inv(7)(p15q34), in a subset of patients with T-cell acute lymphoblastic leukemia characterized by CD2 negative and CD4 positive, CD8 negative blasts. This rearrangement juxtaposes the distal part of the HOXA gene cluster on 7p15 to the TCRb locus on 7q34. Real time quantitative PCR analysis for all HOXA genes revealed high levels of HOXA10 and HOXA11 expression in all inv (7) positive cases. This is the first report of a recurrent chromosome rearrangement targeting the HOXA gene cluster in T-cell malignancies resulting in deregulated HOXA gene expression (particularly HOXA10 and HOXA11) and is in keeping with a previous report suggesting HOXA deregulation in MLL-rearranged T-and B cell lymphoblastic leukemia as the key factor in leukaemic transformation. Finally, our observation also supports the previous suggested role of HOXA10 and HOXA11 in normal thymocyte development.
Introduction
T-cell acute lymphoblastic leukemia (T-ALL) represents 10-15% of childhood and 25% of adult ALLs, and are associated with an intermediate prognosis within the total group of ALLs. 1 In T-ALL, chromosomal rearrangements affecting the T-cell receptor loci (TCR) were among the first to be detected. Similar to translocations involving the IGH locus, these chromosomal changes cause ectopic expression of target genes due to juxtaposition to TCR gene enhancers. These pivotal studies showed that T-ALLs were genetically very heterogeneous with the most frequently detected translocation, the t(11;14)(p15;q11), being found in less than 10% of cases. 2 One particular rare translocation, t(1;14)(p32;q11), lead to the discovery of the TAL1(SCL) gene that turned out to be of crucial importance in normal T-cell development. Most interestingly, TAL1(SCL) was later shown to be transcriptionally activated due to a cryptic 90 kb interstitial deletion in as much as 20% of T-ALLs, thus representing the most frequent genetic abnormality in this disease. 3 Similarly, other T-cell leukemia specific genes (HOX11, LYL1, LMO1, LMO2, HOX11L2), initially identified through rare chromosomal rearrangements involving TCR loci, were also shown to be transcriptionally activated in T-ALLs without evidence for particular translocations. Also, recent studies showed biallelic overexpression of some of these genes thus further supporting the notion for a broader implication in T-ALL through mechanisms other than the known translocation events. 4 Furthermore, the unexpected finding of amplification of a NUP214/ABL1 fusion gene in a minority of T-ALL patients, 5, 6 further illustrated the diversity of genetic events involved in T-ALLs. Likewise, the NOTCH1 gene, involved in the t(7;9)(q34;q34) in less than 1% of T-ALLs, was shown to harbor activating mutations in more than 50% of T-ALLs. 7 Although involvement of each of the three TCR loci in recurrent chromosomal changes in T-ALL is well recognized, 8 both the incidence and the exact contribution of each of these loci in recurrent chromosome abnormalities have not yet been assessed in detail. The finding of a previously unreported t(7;11)(q34;q24) in a child with T-ALL, as the result of a multicolor fluorescence in situ hybridization (M-FISH) study on T-ALLs, prompted us to screen a large cohort of 94 patients with T-ALL. This resulted in the finding of a new recurrent chromosomal rearrangement, that is, a pericentric inversion of chromosome 7, inv(7)(p15q34), in a subset of T-ALL patients. This inversion was associated with an elevated expression of HOXA10 and HOXA11, most probably due to juxtaposition near strong enhancers embedded within the TCRb locus. This is the second report providing evidence for involvement of class I HOXA genes in the development of T-ALL.
Materials and methods

Patients and thymocytes
Diagnostic bone marrow, peripheral blood or pleural fluid samples from 49 adults and 45 children with T-ALL were collected from three institutes, retrospectively. For 32 T-ALL cases (16 children and 16 adults) frozen cells were available for expression analysis. These selected cases contained all cases positive for TCRb chromosomal rearrangement and 13 cases without TCRb rearrangement, which were investigated by FISH (see below). Table 1 lists biological and cytogenetic findings for these patients. Total child thymocyte suspension (CT) and purified CD34 þ thymus cells (CD34 þ T) were isolated as described before. 9 
Immunophenotyping
Immunophenotypic studies were carried out in the respective centers according to established protocols. Cases were classified using the European Group for the Immunological Characterization of Leukemias (EGIL) recommendations. 10 Briefly, EGIL T1 (pro-T ALL) was defined by the presence of only CD7, T2 (pre-T ALL) by CD2 and/or CD5 and/or CD8 positivity, T3 (cortical T-ALL) by CD1a positivity and T4 (mature T-ALL) by the presence of surface CD3 and lack of CD1a.
Cytogenetic studies
The different diagnostic specimens (bone marrow, blood and pleural fluid) were cultured and harvested for cytogenetic analysis according to established methods. Chromosome slides were G-, Q-or R-banded. Chromosome aberrations are described according to guidelines of an International System for Human Cytogenetic Nomenclature (ISCN 1995).
11 Table 1 Biological characteristics and cytogenetic findings of TCRb positive (case n1 1-19; with identified partner gene) and negative T-ALL patients (case n1 [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] (Figure 2 ). For further delineation of the TCRb breakpoint, following gene covering clones were selected: RP11-785K24 (centromeric) and RP11-701D14 (telomeric) (Figure 3 ). RPCI-11 (Human BAC Library) clones were provided by the Welcome Trust Sanger Institute (Cambridge, UK) and Invitrogen (Paisley, Scotland). Clone DNA isolation, labeling and FISH were performed as previously described, 12 using biotin-16-dUTP and digoxigenin-11-dUTP (Roche Diagnostics Belgium, Vilvoorde, Belgium) as haptens.
Disruption of the TCRb locus was assessed by dual color FISH with TCRb flanking probes (RP11-1220K2 and RP11-556I13). Cases carrying TCRb chromosomal rearrangement (identified by a split signal of the flanking probes) were further analyzed to confirm the presumed TCRb partner genes using flanking probes for the respective partner loci (RBTN1 on 11p15, RBTN2 on 11p13, HOX11 on 10q24, TAN1 on 9q34, TAL1(SCL) on 1p32). For those cases, which showed inversion of the distal TCRb flanking probe to 7p, dual color FISH using HOXA flanking probes was performed.
Hybridization signals were evaluated by two independent observers and interpreted at the interphase (100 nuclei) and metaphase level (when available).
RNA isolation, cDNA synthesis and quantitative real-time RT-PCR
Patients were selected retrospectively on the basis of the availability of frozen material at diagnosis. All human samples were obtained according to the guidelines of the local ethical committees. These included 13 TCRb positive cases including five inv(7) positive and 13 TCRb negative cases. Cells obtained from total child thymus (CT), and purified CD34 þ thymocytes (CD34 þ T) were used as a reference for HOX gene expression in normal developing T-cells. 13 RNA was isolated using Trizol (Invitrogen, Merelbeke, Belgium) and RNeasy Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. DNase treatment, cDNA synthesis, primer design and SYBR Green I quantitative real-time RT-PCR were performed as previously described.
14 Reactions were performed on an ABI Prism 5700 Sequence Detector (Applied Biosystems, Foster City, CA, USA). Real-time quantitative PCR data analysis and expression normalization were performed using three internal control genes (RPL13A, UBC, YWHAZ), as described 15 and correlated to the mean expression level of each gene. Primers for HOXA1, HOXA4, HOXA5, HOXA7, HOXA11 were designed according to Thompson et al. 16 Primers for the other HOXA genes (HOXA2, HOXA3, HOXA6, HOXA9, HOXA10, HOXA13) and for HOXB3 and HOXC4 expression analysis were designed and developed according to Wang et al 17 at the Primer Bank. Primer sequences for the tested genes are deposited in RTPrimerDB, a public database for real-time PCR primers (http://medgen.ugent.be/rtprimerdb) (RTPrimerDB). 18 
Data analysis
Statistical analysis was performed using SPSS Software (SPSS Inc., Chicago, IL, USA) version 12.0. The nonparametric MannWhitney U test (two-tailed) was used to evaluate the significance of difference in mean expression levels between the patients subgroups (inv(7) positive vs inv(7) negative patients). The Fisher exact test was used to evaluate the relationship between the specific immunophenotype and the presence of the inv(7).
Results
Frequency of chromosomal rearrangements affecting the TCRb locus in T-ALL
A previously conducted M-FISH analysis in one T-ALL patient (case no. 1) with a known t(1;14)(p32;q11) and TAL1(SCL) overexpression, uncovered a cryptic translocation t(7;11)(q34;q24) affecting the TCRb locus. No known T-cell oncogene is located on distal 11q and breakpoint analysis is currently ongoing. FISH screening for TCRb chromosomal rearrangements in a large series of 93 T-ALLs yielded split signals for the TCRb locus in 18 cases, which brings the total of detected TCRb alterations to 20% (19/94) . In six of these 19 cases, the distal probe for TCRb was translocated to recurrent TCRb partner genes: TAL1 (case no. 2), RBTN2 (case no. 7), RBTN1 (cases no. 9-10), TAN1 (case no. 12), HOX11 (case no. 14) as confirmed by FISH with the appropriate probes ( Table 1) . In eight of the 19 cases showing TCRb rearrangement, involvement of known partner genes was excluded. Interestingly, in five other cases with split signals for the TCRb flanking probes, the telomeric BAC clone for TCRb moved to the distal end of the short arm of chromosome 7, thus revealing the presence of a pericentric inversion with an unknown partner gene (Figure 1a ).
Biological characteristics, immunophenotyping and cytogenetics
Biological characteristics for all TCRb positive cases (cases no. 1-19) and selected TCRb negative T-ALLs (case no. 20-32) are summarized in Table 1 . TCRb positive cases with inv(7), aged 15-49 years (median 32 years), showed an M/F ratio: 1.5:1.0. TCRb positive cases without inv (7) showed a lower age of onset compared to inv(7) positive cases: median 16.6 years (range 4-45 years) and a pronounced male predominance (M/F ratio 3.6:1.0). Compared to inv(7) positive cases, TCRb negative cases also showed a lower age of onset with a median of 21.8 years (range 3-45 years) and a striking male predominance (M/F ratio 12:1).
Immunophenotypic findings from all but two cases are listed in Table 2 . Inv(7) positive cases were classified as either T3 (n ¼ 1) or T4 (n ¼ 4) T-ALL immunophenotypes but with a distinct pattern of CD2 and CD8 negativity and CD1a, CD4, CD5, CD7 and CD10 positivity. Four inv(7) positive cases were analyzed for CD13 and CD33 expression and were found to be negative.
Cytogenetic analysis showed abnormal karyotypes in 11 out of 19 TCRb positive cases (Table 1) . Translocations affecting the 7q34 locus were detected upon banding analysis in three of 19 cases and partial deletions of chromosome 7q or 7p in three cases; one case showed additional material on 7q. Altogether, TCRb genomic rearrangement was unsuspected from cytogenetic analysis in 16/19 cases, partly due to inferior quality of metaphase chromosomes in T-ALL. Details on cytogenetic findings for all 94 cases including additional FISH analysis for the other TCR loci will be reported elsewhere (Cauwelier et al, in preparation).
Inv(7)(p15q34) is a new recurrent rearrangement in T-ALL
Since the HOXA gene cluster is known to be involved in normal human T-cell development, 13 this locus was considered as candidate partner gene for rearrangement with the TCRb locus.
Therefore, dual color hybridization was performed on the inv(7) positive cases using probes flanking the HOXA gene cluster located at 7p15 (RP1-167F23 telomeric and RP5-1103I5 centromeric clones). In all five inv(7) positive cases, a split for the HOXA flanking probes was observed, with the telomeric clone being inverted to distal 7q (Figure 1b) . To confirm these results, we combined the centromeric flanking TCRb probe RP11-1220K2 with the telomeric HOXA flanking probe RP1-167F23, which yielded the expected fusion signals on the inverted chromosome 7 in metaphases as well as in interphase nuclei (Figure 1c) . T4 T4 T4 T4 T4 T4 T4 T4  T4 T3 T3 T3 T3 T4  T4 T4 T4 T3 T2 T4 T2 T4 T4 T3 T4 T4 ? T4 T4 Case numbers correspond to those in table n11. Antigens are arranged in order in which they appear during T-cell differentiation.
HOXA gene expression in T-ALL with inv(7)(p15q34) F Speleman et al
Further characterization of the chromosome 7p breakpoint using three different probe combinations covering the HOXA locus ( Figure 2 ) yielded similar hybridization patterns in all five inv(7) positive cases. For each of the three probe combinations (centromeric clone RP11-1025G19 combined with more telomeric located clones RP11-1036C18, RP11-163M21 or RP11-1132K14, respectively) split signals of the combined probes and complete (RP11-1036C18, RP11-163M21) or partial (RP11-1132K14) inversion of the more telomeric located probes were observed (Figure 1d-f) . Consequently, these experiments further confirmed the localization of the inversion 7p15 breakpoint within the HOXA gene cluster and more specifically allowed us to assign the breakpoint to the region covered by BAC clone RP11-1132K14. Given the relative position of the four BAC clones used in these experiments and absence of disruption of RP11-1036C18, RP11-163M21 or RP11-1025G19, we assume that the most probable position of the 7p15 breakpoint is within a B20 kb segment located between HOXA5 and HOXA9 (Figure 2) .
Two clones spanning most of the TCRb locus (RP11-785K24 centromeric and RP11-701D14 telomeric) revealed split signals in all inv(7) positive cases (Figure 1g) , and thus confirmed the involvement of the TCRb gene in the inv(7) positive cases ( Figure 3) . Moreover, in two inv(7) positive cases a partial deletion of the centromeric TCRb probe in 95% (case no. 15) and 96% of cells (case no. 18) carrying the inversion was observed.
Real time quantitation of gene expression for HOXA, HOXB3 and HOXC4 genes Expression level measurements of all eleven members of the HOXA gene cluster (HOXA1, HOXA2, HOXA3, HOXA4,  HOXA5, HOXA6, HOXA7, HOXA9, HOXA10, HOXA11 and   HOXA13 ) were performed on a total of 26 patient samples, total CT and CD34 þ purified child thymocytes (CD34 þ T). Patient samples included five inv(7) positive cases (group A), eight TCRb positive without inv(7) (group B) and 13 TCRb negative selected cases (group C). As no significant differences in the observed expression pattern was noted for group B as compared to group C (Student's t-test: P40.05), both patient groups were joined and inv(7) positive cases were compared to inv (7) negative cases. A high HOXA10 and HOXA11 expression was noted for all inv(7) positive cases whereas two inv(7) negative T-ALLs showed similar increased levels of HOXA10 and HOXA11 transcripts (cases no. 21 and 22) (Figure 4A, B) . Levels of HOXA10 and HOXA11 expression in total CT and CD34 þ purified child thymocytes were comparable but at least 10-fold lower than the mean expression of these genes in inv (7) positive T-ALL samples. HOXA11 expression levels were statistically significant increased in the inv(7) positive cases vs inv(7) negative cases (P ¼ 4.5 Â 10E-4 and P ¼ 8.8 Â 10E-4, respectively), the latter showing only marginal expression for HOXA10 and HOXA11. HOXA9 expression was slightly increased in inv(7) positive patients as compared to the inv(7) negative samples (P ¼ 1.8 Â 10E-3). Remarkably, in one inv(7) positive case (no. 15), all other HOXA genes also showed increased expression ( Figure 4C(a) and (b) ). Likewise, one inv(7) negative case (no. 28) showed elevated expression for all HOXA genes except for HOXA11 (Figure 4C(a) and (b) ). For these three cases showing elevated expression for HOXA10 and/or HOXA11 (cases no. 21, no. 22, no. 28), dual color FISH using the HOXA flanking probes was performed to evaluate disruption of the HOXA gene cluster but no evidence for any disruption of the HOXA gene cluster was found.
In addition to HOXA gene expression, we tested the inv(7) positive patients, total CT cells and CD34 þ purified child thymocytes (CD34 þ T) for expression of HOXB3 and HOXC4 HOXA gene expression in T-ALL with inv (7)(p15q34) F Speleman et al gene expression since, according to Taghon et al, 13 these were the only homeobox genes apart from HOXA7, HOXA9, HOXA10 and HOXA11 that were expressed at all major stages of human thymopoiesis. In comparison with child thymocytes and CD34 þ purified child thymocytes, HOXB3 was only weakly expressed in the inv(7) positive patients whereas HOXC4 expression was clearly detected in all inv(7) positive patients and slightly higher than expression levels of total child thymocytes and CD34 purified child thymocytes ( Figure 5 ).
Discussion
In this study, we describe a new recurrent chromosomal alteration, a pericentric inversion of chromosome 7, inv(7)(p15q34), in five patients with T-ALL leading to disruption of the HOXA gene cluster and juxtaposition to sequences within the TCRb locus. As a consequence of this rearrangement, increased HOXA10 and HOXA11 expression was evident in all inv(7)(p15q34) positive cases as compared to most inv(7) negative T-ALLs.
A number of findings support our assumption that this inv(7)(p15q34) indeed represents a new recurrent chromosomal abnormality in T-ALL. First of all, FISH results with BAC clones covering the HOXA gene cluster at 7p15 were similar in all cases and were in keeping with a breakpoint cluster within the B107 kb genomic region containing all HOXA genes, most probably distal to HOXA5 and proximal to HOXA10. Second, gene expression analysis showed consistent increased expression of HOXA10 and HOXA11 in all inv(7) positive cases. Thirdly, all inv(7) positive T-ALLs were classified as mature TALLs (T3-4 group according to the EGIL recommendations 10 ) but with characteristic CD2 negative CD4 positive, CD8 negative blast cells.
The present study was initially triggered by the finding of a cryptic t(7;11)(q34;q24) in an M-FISH study of childhood ALLs with complex karyotypic rearrangements. Based upon this observation, we anticipated that the distal chromosomal localization of the TCRb locus might also predispose to the formation of other undetected rearrangements, which indeed turned out to be the case as demonstrated by the finding of the recurrent inv(7)(p15q34). In addition to this new discovery, the finding of chromosomal rearrangements affecting the TCRb locus in as much as 20% in an unselected group of T-ALLs is in itself remarkable. Although the study by Gesk et al 8 showed a relatively high proportion of TCRb rearrangements in a series of T-ALLs with cytogenetically detectable rearrangements affecting Figure 4 (A) Geometric averages of normalized expression of HOXA10 in inv(7) positive T-ALL cases (white boxes), inv(7) negative T-ALL cases (black boxes), total child thymocytes (CT) and CD34 þ sorted stem cells (CD34 þ T). (B) Geometric averages of normalized expression of HOXA11 in inv(7) positive T-ALL cases (white boxes), inv(7) negative T-ALL cases (black boxes), total child thymocytes (CT) and CD34 þ sorted stem cells (CD34 þ T). (C (a and b) ) Global overview of normalized expression of all class I HOX genes tested in inv(7) positive T-ALLs (cases no. [15] [16] [17] [18] [19] , inv(7) negative T-ALLs (cases no. 2-11 and no. 20-32) and total child thymocytes (CT).
Figure 5
Geometric averages of normalized expression of HOXB3 and HOXC4 in inv (7) positive T-ALL cases (no. [15] [16] [17] [18] [19] , total child thymocytes (CT) and CD34 þ sorted stem cells (CD34 þ T).
the TCR loci, no systematic study on unselected cases investigating TCRb rearrangements has been reported thus far. The high percentage of TCRb rearrangements is only partly explained by the presence of the five inv(7) cases. Indeed, for 8/ 19 TCRb positive cases, FISH screening for known TCRb partners was negative and further testing for partner identification is currently ongoing. In addition, some chromosomal disruptions of the TCRb locus were found in patients with apparent normal karyotypes and representing partly cryptic rearrangements with known T-cell oncogenes such as RBTN2 and RBTN1 with subtelomeric localization.
Homeobox genes are a particular class of transcription factors that play an important role in regulating aspects of morphogenesis and cell differentiation during normal embryonic development. Class I HOX genes are located in tightly linked physical clusters, whereas class II HOX genes are dispersed throughout the genome. In humans, a total of 39 class I HOX genes are located in four distinct gene clusters on 7p15.3 (HOXA), 17q21.3 (HOXB), 12q13.3 (HOXC) and 2q31.1 (HOXD). 19 They encode a complex network of transcription regulatory proteins whose precise targets remain poorly understood. HOX genes were shown to play a significant role not only in regulating body formation but also in organization and regulation of hematopoiesis 20 and leukemogenesis. [21] [22] [23] Direct effects of class I HOX gene function in hematopoiesis have been shown in various studies where HOX gene expression has been modulated by antisense oligonucleotides, 24, 25 gene disruption by homologous recombination 26, 27 or by overexpression studies. [28] [29] [30] [31] In brief, forced expression of HOXA10 in murine 31, 32 and cord blood 28, 29 hematopoietic stem cells resulted in increased proliferation and impaired myeloid differentiation besides a profound reduction in B and T cell differentiation. HOXA9 overexpression studies showed similar effects in myeloid lineages but without effect on T lymphoid development. 33 Both overexpression studies of HOXA10 and HOXA9 however failed to produce any lymphoid neoplasms. In myeloid leukemia, several class I HOX genes have been implicated predominantly due to formation of fusion transcripts with NUP98. 34 A role for class I homeobox genes in T-ALL was first suggested by Ferrando et al, 35 who demonstrated consistently increased expression levels of a subset of HOX genes (HOXA9, HOXA10, HOXC6 and MEIS1) in MLL rearranged T-and B-ALL, while myeloid lineage genes were only expressed in MLL rearranged B-ALL and not in T-ALL cases. These findings suggested HOX gene deregulation rather than myeloid gene deregulation being the key factor in leukaemic transformation mediated by MLL fusion proteins. 35 Further support for a crucial role of HOXA genes came from a study of HOXA gene expression in developing thymocytes 13 where high HOXA10 expression was found in the earliest T-cell precursors in human thymus, which showed subsequent downregulation in CD4 and CD8 single positive mature thymocytes. This observation suggested a role for HOXA10 in T-cell maturation, which was in keeping with their previous studies that showed impairment of final T-cell differentiation upon enforced HOXA10 expression in cord blood cells. 29 In contrast to HOXA genes, expression of the other HOX cluster genes was less prominent or absent except for HOXB3 and HOXC4. HOXA11 was expressed at all major stages of T-cell development also underlining the putative important role of this particular HOX gene in thymocyte maturation. Taken together, the present findings and published data on HOXA expression in T-cell precursors and maturing thymocytes strongly suggest that the HOXA gene cluster and HOXA10 and HOXA11 genes, in particular, are of crucial importance in normal T-cell development.
In contrast to class I homeobox genes, two particular class II homeobox genes has been extensively studied in T-ALL, that is HOX11, initially discovered through the t(10;14)(q24;q11), 36 and HOX11L2 more recently shown to be implicated in the cryptic t(5;14)(q35;q32). 37 Chromosomal rearrangements disrupting HOX gene clusters might also shed light onto the mechanisms controlling HOX gene expression, that is, locally cis-acting control sequences, global enhancer sequences located outside the gene clusters. 38, 39 Here, we propose two possible oncogenetic mechanisms resulting from the inv(7). First, the disruption of the HOXA gene cluster could interfere with the normal scheduled program of sequential up and downregulation following the 3 0 to 5 0 localization of the HOXA genes, that is, 3 0 region HOXA genes being expressed in the more primitive cells and 5 0 genes in more differentiated cells. The physical disruption of the cluster could therefore block downregulation of HOXA10 and HOXA11 required in order to allow the cells to complete their further differentiation and maturation. The second and more classical hypothesis is that enhancers embedded within the TCRb locus lead to sustained high expression levels of HOXA10 and HOXA11. Based upon the 10-fold higher expression levels observed for HOXA10 and HOXA11 in the inv(7) positive cases as compared to normal developing thymocytes, we favor the latter hypothesis.
Immunophenotypically, the five inv (7) patients showed a distinct pattern of CD2 negativity and CD4 single positivity within the T3-4 subgroup of T-ALLs. Obviously, lack of CD2 expression on their leukaemic blasts is the most striking feature as this pan T-cell marker is present on the leukaemic blasts of 85% of T-ALL. 40 CD4 single positivity is another intriguing finding within the T3-4 group as most cases either show CD4/ CD8 double positivity or CD8 single positivity. Taken together, the phenotypic combination of CD2À, CD4 þ and CD8À showed significant correlation with the presence of the inv(7) genomic rearrangement (P ¼ 5 Â 10E-5).
In addition to the inv(7)(p15q34) positive cases, our study indicates that other mechanisms can lead to abnormal HOXA gene expression as two inv(7) negative cases also showed an elevated HOXA10 and HOXA11 expression. Moreover, a third case was noted, which like one of the inv(7) positive cases, showed upregulated expression of all HOXA genes. This observation is intriguing and somewhat reminiscent to the observed enhanced expression of certain T-cell oncogenes (HOX11, LYL1, TAL1, LMO1 and LMO2) in the absence of any detectable chromosomal rearrangement affecting these loci. 41 Further study of these remarkable cases might increase our understanding of the mechanisms governing the tight control of expression of these developmentally important genes.
In conclusion, the present report describes a new recurrent cryptic chromosomal inversion inv(7)(p15q34) in T-ALL,which leads to elevated expression of HOXA10 and HOXA11 in five cases and increased expression of all HOXA genes in one case and seems to delineate a specific subset of CD2 negative CD4 single positive T-ALLs. This observation for the second time implicates class I HOXA genes, and in particular HOXA10 and HOXA11, in T-cell oncogenesis and strongly supports the previously proposed role for HOXA genes in thymocyte development. We are currently collecting additional cases of inv(7) patients in order to determine in more detail the clinical and biological profile of this patient subgroup and, most importantly, in order to assess the prognostic importance of inv(7)(p15q34) within a large cohort of uniformly treated patients. Finally, we anticipate that this study might trigger a search for compounds interfering with T-cell differentiation pathways controlled by HOXA genes and will also stimulate new investigations focused at determining the role of HOXA genes in T-cell development.
